Current University of Texas Interim President Jay Hartzell was unanimously voted president by the University of Texas System Board of Regents Wednesday, effective immediately.
The vote comes after he was named the sole finalist for the position last month and serving in the interim position since April.
"In the short time Jay has been interim president, he has led UT Austin with a steady hand and an eye on the future," Board Chairman Kevin P. Eltife said in a press release. "Jay continues to demonstrate that he is a leader who can manage enormous challenges and still maintain a focus on elevating the academic, research and clinical missions of a world-class institution."
.@utsystem Board of Regents unanimously votes to appoint @JCHartzell the 30th president of The University of Texas… https://t.co/ZjEOyCOIKM— UT Austin (@UT Austin)1600871952.0
Hartzell has a long history with UT, having earned his Ph.D. in 1998 from the university. He went on to become a faculty member in 2001, holding various administrative positions. Before serving as interim president he was the dean of the McCombs School of Business.
"I'm humbled that Chairman Eltife, the members of the UT System Board of Regents and Chancellor Milliken have given me the honor of a lifetime, selecting me to serve as the next President of The University of Texas at Austin," Hartzell said in a press release. "This is a dream come true for me because it means that I get the chance to go to work with students, faculty, staff and alumni and put all my energy into helping Longhorn Nation do what it does best—change the world."
More on UT:
- Fenves ends term at UT - austonia ›
- Former UT tennis coach Michael Center in halfway house after ... ›
- UT plans on Longhorns football in fall 2020 - austonia ›
- UT Austin students gathered without masks get blasted on social ... ›
Austin's new infusion center offers free antibody treatment to COVID patients—but capacity remains limited
More than 120 COVID-19 patients have received the monoclonal antibodies treatment, Regeneron, at the Austin Regional Infusion Center in Montopolis since it opened on Jan. 6.
This comes as good news to John Doucette, a 52-year-old realtor who, for the last six months, has participated in a Regeneron clinical trial conducted by the Austin-based company Benchmark Research.
- Austin opens COVID field hospital as ICUs near capacity - austonia ›
- We Are Blood requests funding for convalescent plasma program ... ›
- Plasma may help COVID-19, Austin doctors say as they join national ... ›
- Antibody tests show up in Austin, but not all are FDA approved ... ›
After a truly impactful year on the aviation industry, Norwegian Air announced that due to COVID-19 and government advice discouraging travel, it would abandon its long haul flights to focus on its European audience for the time being.
That means Austin-Bergstrom International Airport is losing two European routes: a nonstop route to London and Austin's sole nonstop route to Paris.